Pluto Bio, a Denver, CO-based provider of an AI-powered platform for computational biology, raised $3.6M in funding.
Backers included Kickstart, alongside existing investor Silverton Partners and existing angel investors.
The company intends to use the funds to accelerate growth and scale adoption of its enterprise-grade platform among global pharma companies.
Led by CEO and Founder Dr. Rani Powers, Pluto Bio is an AI-powered data management, analysis, and visualization platform for multi-omics. Designed for pharma, it enables scientists to analyze, visualize, and collaborate on large-scale biological data without writing code. From target discovery to translational medicine, the company empowers R&D and translational science teams to turn complex datasets into better insights.
The platform is used by mid-market and enterprise clients across North America and Europe, with users spanning discovery biology, translational research, and computational teams.
FinSMEs
14/05/2025